Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/18857Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Tsatsoulis, A. | en |
| dc.contributor.author | Shalet, S. M. | en |
| dc.contributor.author | Talbot, A. | en |
| dc.contributor.author | Robertson, W. R. | en |
| dc.date.accessioned | 2015-11-24T18:55:20Z | - |
| dc.date.available | 2015-11-24T18:55:20Z | - |
| dc.identifier.issn | 0300-0664 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/18857 | - |
| dc.rights | Default Licence | - |
| dc.subject | Adult | en |
| dc.subject | Biological Assay | en |
| dc.subject | Drug Administration Schedule | en |
| dc.subject | Humans | en |
| dc.subject | Hypogonadism/*blood/drug therapy | en |
| dc.subject | Luteinizing Hormone/blood/*secretion | en |
| dc.subject | Male | en |
| dc.subject | Pituitary Hormone-Releasing Hormones/administration & dosage/*therapeutic use | en |
| dc.title | Quantitative and qualitative changes in LH secretion following pulsatile GnRH therapy in a man with idiopathic hypogonadotrophic hypogonadism | en |
| heal.type | journalArticle | - |
| heal.type.en | Journal article | en |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/2692879 | - |
| heal.identifier.secondary | http://onlinelibrary.wiley.com/store/10.1111/j.1365-2265.1989.tb03738.x/asset/j.1365-2265.1989.tb03738.x.pdf?v=1&t=h0ousr14&s=34ed7858639ca0e0fb00276b7fb502979933427d | - |
| heal.language | en | - |
| heal.access | campus | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.publicationDate | 1989 | - |
| heal.abstract | The pattern of bioactive and immunoreactive LH secretion before and during pulsatile GnRH therapy (18 micrograms/90 min) in a hypogonadotrophic hypogonadal male has been studied. Before treatment the patient was azoospermic and had low testosterone (1.2 nmol/l) with low and apulsatile immunoreactive LH (1.9 +/- 0.2 IU/l) and FSH (1.4 +/- 1.9 IU/l) levels. There was no detectable LH bioactivity. During the first 24 h of GnRH therapy there was a small increase in immunoreactive (5.4 +/- 0.8 IU/l) and bioactive (6.7 +/- 1.3 IU/l) LH, with an irregular pattern and little effect on testosterone production (2.2 nmol/l). Within 1 week of treatment both bioactive (30.5 +/- 6.8 IU/l) and immunoreactive (13.6 +/- 1.5 IU/l) LH levels were above the normal range and the pattern of secretion was pulsatile. The bioactive to immunoreactive (B:I) LH ratios within the pulses (2.6 +/- 0.3) were higher (P less than 0.01) than between pulses (1.97 +/- 0.1) and the testosterone concentration (17.8 +/- 2.1 nmol/l) was now normal. At one month LH secretion was similar and testosterone pulses of high amplitude were evident corresponding to high-amplitude bioactive LH pulses. By 3 months mature spermatozoa (1.3 x 10(6)/ml) were seen in the patient's semen. The pattern of LH secretion was pulsatile but the levels of bioactive (13.1 +/- 3.6 IU/l) and immunoreactive (9.5 +/- 1.3 IU/l) LH decreased towards the normal range reflecting maturation of the testicular feedback control at the pituitary level. This effect was more pronounced on bioactive rather than immunoreactive LH secretion (57% vs 32% relative decrease). At 6 months LH levels were similar and the sperm count was normal (34 x 10(6)/ml). | en |
| heal.journalName | Clin Endocrinol (Oxf) | en |
| heal.journalType | peer-reviewed | - |
| heal.fullTextAvailability | TRUE | - |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Tsatsoulis-1989-Quantitative and qua.pdf | 538.94 kB | Adobe PDF | View/Open Request a copy |
This item is licensed under a Creative Commons License
